COVID-19 trials registries data warehouse

 Return to trial list

Trial - EUCTR2020-001209-22-GB


Column Value
Trial registration number EUCTR2020-001209-22-GB
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

First author
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

University of Oxford - Chief Investigator

Contact
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

principle@phc.ox.ac.uk

Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2020-03-25

Recruitment status
Last imported at : Jan. 4, 2021, 1:30 a.m.
Source : EU Clinical Trials Register

Recruiting

Study design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

RCT

Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Randomized

Design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Parallel

Masking
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Open label

Center
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

multi-center

Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Participant is willing and able to give informed consent for participation in the study. Participant is willing to comply with all trial procedures Onset of symptoms of possible COVID-19 in the community (continuous cough and/or high temperature) within 7 days of inclusion Patients aged ≥50-64 years with any of the following listed comorbidities: - known weakened immune system due to a serious illness or medication (e.g. chemotherapy) - known heart disease - known asthma or lung disease - known diabetes not treated with insulin - known mild hepatic impairment - known stroke or neurological problem OR Patients aged ≥65 with or without comorbidity

Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Pregnancy Breastfeeding Known severe hepatic impairment Known severe renal impairment Known acute porphyrias Type 1 diabetes or insulin dependent Type 2 Diabetes mellitus Known G6PD deficiency Known myasthenia gravis Known severe Psoriasis Known severe neurological disorders (especially those with a history of epilepsy may lower seizure threshold) Previous adverse reaction to, or currently taking, hydroxychloroquine Known retinal disease Judgement of the recruiting clinician deems ineligibile

Number of arms
Last imported at : Nov. 13, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

2

Funding
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

University of Oxford / Clinical Trials and Research Governance

Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

50

Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

None

Countries
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

United Kingdom

Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Mild disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

1: Mild disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

3000

primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Hospital admission or mortality related to suspected COVID-19.

Notes
Last imported at : Nov. 13, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

Declared number of arm (2.0) differs from found arms (4.0)

Phase
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Phase 3

Arms
Last imported at : Nov. 13, 2020, 12:30 a.m.
Source : EU Clinical Trials Register

[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]